Depomed Inc. Reaches New 12-Month High at $12.88 (DEPO)
Depomed (NASDAQ:DEPO)’s share price reached a new 52-week high on Wednesday, Analyst Ratings News reports. The company traded as high as $12.88 and last traded at $12.12, with a volume of 927,732 shares traded. The stock had previously closed at $11.75.
A number of analysts have recently weighed in on DEPO shares. Analysts at JMP Securities raised their price target on shares of Depomed from $10.00 to $11.00 in a research note to investors on Wednesday, December 18th. They now have an “outperform” rating on the stock. Analysts at Roth Capital raised their price target on shares of Depomed from $9.00 to $11.00 in a research note to investors on Friday, November 22nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Depomed has an average rating of “Buy” and an average price target of $10.00.
Depomed has a 52 week low of $4.99 and a 52 week high of $12.55. The stock has a 50-day moving average of $10.56 and a 200-day moving average of $8.10. The company’s market cap is $678.7 million.
Depomed (NASDAQ:DEPO) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. The company had revenue of $37.50 million for the quarter, compared to the consensus estimate of $35.55 million. During the same quarter last year, the company posted ($0.03) earnings per share. Depomed’s revenue was up 12.6% compared to the same quarter last year. On average, analysts predict that Depomed will post $-0.18 earnings per share for the current fiscal year.
Depomed, Inc (NASDAQ:DEPO) is a specialty pharmaceutical company initially focused on neurology, pain and other diseases of the central nervous system.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.